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Padua, Rovigo, Pavia, and Verona, ItalyQuestionable systolic assistance and latissimus dorsi (LD)
degeneration have been considered the main drawbacks of
dynamic cardiomyoplasty since its creation by Carpentier
and Chachques.1 With the hope of improving systolic assis-
tance and reducing muscular damage, fewer impulses per
day were delivered than with the standard clinical stimula-
tion protocol. This was achieved by providing the LD
wrap with daily periods of rest (demand stimulation) on
the basis of a heart rate cutoff.2 We present the results after
10 years of demand dynamic biogirdling (DDBG) in Italy.
METHODS
We retrospectively reviewed clinical, echocardiographic, mechano-
graphic, and cardiac invasive assessment records of 14 patients (13 men,
1 woman, mean age 58.3 5.7 years, sinus rhythm n¼ 12, atrial fibrillation
n ¼ 2) with idiopathic dilated cardiomyopathy and congestive heart failure
who underwent dynamic cardiomyoplasty from 1993 to 1996 according to
the protocol of Carpentier and Chachques.1 Informed consent was obtained
from all patients.
The demand stimulation protocol was introduced in the hope of avoiding
complete LD wrap transformation caused by the continuous stimulation
protocol of the US Food and Drug Administration phase 2 trial used by
the American Cardiomyoplasty Group.3 It is well known that a muscle
that has been fully transformed by continuous stimulation displays signifi-
cant loss of power, generally attributed to fiber type change or to the loss
of type 2 myofibers (fast-contracting myofibers). The inclusion of daily
rest periods during long-term burst electrical conditioning maintains myo-
fiber cross-sectional area, produces fatigue-resistant myofibers with faster
contraction speed, and creates a more powerful, fatigue-resistant muscle.
The LD was stimulated with a single impulse at a 1:3 synchronization ratio
after a healing period of 10 to 14 days. An extra impulse was then added
every week at a 23-ms interval (43 Hz) for a final burst of four impulses,
with a cardiac amplitude more than 5 V and pulse width of 1.5 ms. After
6 to 12 months of this light daily stimulation, the patients took part in the
demand regimen, which gave the LD wrap a daily period of rest.2 To pro-
vide the LD wrap with daily periods of rest, a 24-hour Holter study was first
performed to determine the average heart rate during sleep. The pacing vari-
ables of the cardiomyostimulator (Transform model 4710; Medtronic, Inc,
Minneapolis, Minn) were programmed at a rate of 70 to 80 beats/min,
with minimum pulse amplitude (<1 V) and pulse width (<0.05 ms). Muscle
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events and not with paced events. The result was that muscle stimulation
was inhibited during the resting hours and occurred at the programmed syn-
chronization ratio during activity, providing an activity–rest stimulation reg-
imen. The demand protocol was electively introduced in 4 patients from the
Italian Trial of Demand Dynamic Cardiomyoplasty and in 10 patients who
had previously undergone dynamic cardiomyoplasty, in an attempt to alle-
viate worsening clinical condition during dynamic cardiomyoplasty with
continuous stimulation with no short-term to midterm prospect of heart
transplant.
Dynamic contractile characteristics of the LDwrap (speed of contraction
and relaxation) can be monitored with a standard polygraph (MegaCart or
Mingophon; Siemens-Elema AB, Solna, Sweden) in combination with
monitoring of electrocardiogram and pressure changes caused by LD con-
traction. The dynamic characteristics of the LD wrap are determined by
the LD’s response to stimuli delivered at increasing frequency up to the te-
tanic fusion frequency (the higher the tetanic fusion frequency, the faster
and more powerful the fibers). This method is also used for monitoring car-
diac/LD contraction synchronization.
RESULTS
In immediate and interim follow-up (41.4  17.5
months, range 23–69 months), there were no perioperative
deaths. After a mean duration of demand stimulation of
40.2  13.8 months, all the clinical and instrumental pa-
rameters calculated had improved significantly relative to
preoperative values (Table 1). The actuarial 5-year survival
(freedom from death or transplant) was 46.36%; the overall
survival was 115.4  18 months (range 89–134 months).
At 10-year follow-up, 3 patients had died of noncardiac
causes, 3 patients had died of cardiac-related causes, 4 pa-
tients had been switched to transplant, and 2 had been im-
planted with biventricular pacemakers. Two patients were
alive without events. The 10-year actuarial survival (free-
dom from death or transplant) was 28.6% (Tables 1 and
2). Survivors had a trend toward younger age (54.3 
8.0 years vs 61.8  6.7 years, P ¼ .84) and shorter dura-
tion of the old standard stimulation protocol before the
start of demand stimulation (58  19 months vs 41  8
months, P ¼ .054). No difference was seen with regard
to New York Heart Association functional class (all pa-
tients were in New York Heart Association functional
class I), ejection fraction (31%  2% vs 31% 
1.0%), and wedge pressure (13  8.7 mm Hg vs 13.4 
7.6 mm Hg) between living patients with and without im-
plantable cardioverter defibrillator biventricular pacing.
Pathologic data from all hearts excised at transplant or af-
ter death were not available because of geographic disper-
sion of the patients across Italy or significant lack of
uniformity in heart specimen evaluation. We observedgery c January 2009
Brief CommunicationsTABLE 1. Cumulative results at follow-up
P value
Preop (n ¼ 14) 5 y (n ¼ 13) 10 y (n ¼ 4) 5 y vs preop 10 y vs 5 y
NYHA functional class 3.17  0.38 1.67  0.77 1.74  0.83 <.0001 NS
Ejection fraction* 22.6%  4.38% 32.0%  7.0% 30.0%  3.5% <.001 NS
EDLV (mL/m2) 114  41.1 104  9.9 100  7.2 .67 NS
Wedge pressure (mm Hg) 12.2  6.11 11.7  7.19 13.7  9.1 .83 NS
TFF (Hz) 33  7.86 15.8  11.1 16.2  10.4 <.0001 NS
Preop, Preoperative; NYHA, New York Heart Association; NS, not significant; EDLV, end-diastolic volume; TFF, tetanic fusion frequency. *By transthoracic echocardiography.only a trend toward an improved vascularization of the
flap and preserved muscle in patients who died of extrac-
ardiac causes, whereas varying degrees of fat infiltration
and atrophy were present in hearts excised at transplant.
DISCUSSION
From pathologic and morphologic studies, it appears that
muscle degeneration is caused by surgical dissection of the
muscle and is exacerbated by long-term stimulation.4
These findings led to the concept that intermittent burst
stimulation might result in less muscle damage and to a fa-
tigue-resistant, fast-contracting LD wrap, contributing to
more effective cardiac support. Muscular properties, such
as fatigue resistance and speed of myofibers, expressed
by tetanic fusion frequency, and vascular delay at the
time of surgery are the keys to obtaining more powerful
muscles, as demonstrated in our previous studies.2 Our ear-
lier data suggested that maintenance of these muscular
TABLE 2. Clinical data at 10-year follow-up
Patients (n ¼ 14)
No. %
Cardiac-related death
All causes 3 21.4%
Pulmonary embolism 2 14.3%
Arrhythmia-induced cardiogenic shock 1 7.1%
Noncardiac death 3 21.4%
Switch to heart transplant 4 28.5%
Survival free from death or transplant 4 28.5%
Biventricular implantable cardioverter
defibrillator pacing
2 14.3%
New York Heart Association functional class I 4 28.5%The Journal of Thoracic and Cproperties correlated well with the amount of systolic assis-
tance and continued with time with demand stimulation
protocol, probably providing more effective circulatory
support and a quite acceptable survival, with heart trans-
plant or biventricular pacing still possible for such patients.
Although these results could not for many different rea-
sons be directly translated into the clinical practice of
DDBG, abandoned a few years ago, the lessons learned
from DDBG may be of some importance in assessing effec-
tiveness of new surgical techniques and devices, such as the
new passive antidilation devices, and in evaluating the feasi-
bility of muscle engineering techniques by myoblast or myo-
genic stem cell delivery, in which electrical stimulation of
implanted cells may allow avoidance of more specific but
more difficult to manage cellular lines. Moreover, the les-
sons of DDBG may help to accomplish better results in in-
creasing the LD muscle flap angiogenesis induced by
long-term electrical stimulation, opening new strategies for
LD use.5
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